Identification of fungi from Otomycosis patients in Duhok city and their in vitro antifungal susceptibility testing

Soleen A. Sultan; Asia A. M. Saadullah

doi:10.21271/ZJPAS.35.2.15

Authors

Soleen A. Sultan Medical laboratory Department, College of Health Sciences, University of Duhok, Duhok, Iraq
Asia A. M. Saadullah Biology Department, College of Sciences, University of Duhok, Duhok, Iraq

DOI:

https://doi.org/10.21271/ZJPAS.35.2.15

Keywords:

Otomycosis, ENT, Fungi, Yeasts, Antifungal sensitivity test.

Abstract

The aim of this study was to determine the most common causative agents of otomycosis in Duhok city, Iraq; and subsequently study their sensitivity to the most commonly prescribed Drugs. From August 2021 till October 2021, a total of 90 patients (46 females and 44 males) who attended the outpatient clinic of ear, nose and throat (ENT) department at Azadi teaching hospital; were clinically examined for mycotic otitis. Ear debris was collected by sterile swabs and transferred to the laboratory for direct microscopic and macroscopic examination by culturing on sabouraud dextrose agar, potato dextrose agar and CHROM Agar Candida. Antifungal drugs were dissolved with (dimethyl sulfoxide) DMSO and used for evaluation of antifungal sensitivity by agar well diffusion method against commonly used antifungal drugs namely; Fluconazole, Itraconazole, Terbinafine, Nystatin, Amphotericin B, and Clotrimazole. In this study positive fungal infections were found in 88 (97.8%) of the collected samples, and it was more common among patients that aged 40 to 49 years. Mycological examination revealed the isolation of 24 genera and species with one variety. The most common fungal isolates were Candida (88.9%), followed by Aspergillus (28.8%) and non-identified yeast (25%), Penicillium (8.9%). Among the identified species, Candida krusei (44.4%) and Candida albicans (16.7%) followed by Aspergillus niger (15.6%) were the predominant species isolates.

References

Abdelazeem, M., Gamea, A., Mubarak, H. and Elzawawy, N., 2015. Epidemiology, causative agents, and risk factors affecting humanotomycosis infections. Turkish journal of medical sciences, 45(4), pp.820-826.

Adoga, A.S. and Iduh, A.A., 2014. Otomycosis in Jos: Predisposing factors and Management. African journal of medicine and medical sciences, 43(Suppl 1), pp.209-213.

Agarwal, P. and Devi, L.S., 2017. Otomycosis in a rural community attending a tertiary care hospital: assessment of risk factors and identification of fungal and bacterial agents. Journal of clinical and diagnostic research: JCDR, 11(6), p. DC14.

Al-Abbasi, A.M. and Sabbar, B.A., 2011. OTOMYCOSIS IN BASRAH-IRAQ قارعلا-ةرصبلا يف نذلأا راطف. Journal of the Arab Board of Health Specializations Vol, 12(2).

Aneja, K.R., Sharma, C. and Joshi, R., 2010. Fungal infection of the ear: a common problem in the north eastern part of Haryana. International journal of pediatric otorhinolaryngology, 74(6), pp.604-607.

Barati, B., Okhovvat, S.A.R., Goljanian, A. and Omrani, M., 2011. Otomycosis in central Iran: a clinical and mycological study. Iranian red crescent medical journal, 13(12), p.873.

Ellis, D. H., Davis, S., Alexiou, H., Handke, R., & Bartley, R. (2007). Descriptions of medical fungi (Vol.2). Adelaide: University of Adelaide.

Gharaghani, M., Seifi, Z. and Mahmoudabadi, A.Z., 2015. Otomycosis in Iran: a review. Mycopathologia, 179(5-6), pp.415-424. doi: 10.1007/s11046-015-9864-7. Epub 2015 Jan 30.

Ghiacei S. (2008): Survey of Otomycosis in north-western area of Iran. Med J Mashhad Uni Med Sci;(43): 85-7.

Gonzalez, H.H.L., Resnik, S.L., Boca, R.T. and Marasas, W.F.O., 1995. Mycoflora of Argentinian corn harvested in the main production area in 1990. Mycopathologia, 130(1), pp.29-36.

Ismail, M.T., Al-Kafri, A. and Ismail, M., 2017. Otomycosis in Damascus, Syria: Etiology and clinical features. Current medical mycology, 3(3), p.27.

Jia, X., Liang, Q., Chi, F. and Cao, W., 2012. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses, 55(5), pp.404-409.

Klich, M.A., 2002. Identification of common Aspergillus species. CBS.

Magaldi, S., Mata-Essayag, S., De Capriles, C.H., Perez, C., Colella, M.T., Olaizola, C. and Ontiveros, Y., 2004. Well diffusion for antifungal susceptibility testing. International journal of infectious diseases, 8(1), pp.39-45.

Moharram¹, A.M., Ahmed, H.E. and Nasr¹, S.A., 2013. Otomycosis in Assiut, Egypt. Journal of Basic & Applied Mycology (Egypt), 4, pp.1-11.

Ologe FE, Nwabuisi C. Treatment outcome of otomycosis in Ilorin, Nigeria. West Afr J Med 2002; 21:34–6.

Ozcan, K.M., Ozcan, M., Karaarslan, A. and Karaarslan, F., 2003. Otomycosis in Turkey: predisposing factors, aetiology and therapy. The Journal of Laryngology & Otology, 117(1), pp.39-42.

Pontes, Z.B.V.D.S., Silva, A.D.F., Lima, E.D.O., Guerra, M.D.H., Oliveira, N.M.C., Carvalho, M.D.F.F.P. and Guerra, F.S.Q., 2009. Otomycosis: a retrospective study. Brazilian Journal of otorhinolaryngology, 75, pp.367-370.

Prasad, S.C., Kotigadde, S., Shekhar, M., Thada, N.D., Prabhu, P., D’Souza, T. and Prasad, K.C., 2014. Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification. International journal of microbiology, 2014.

Raper, K.B. and Fennell, D.I., 1965. The genus Aspergillus. The genus Aspergillus.

Saki, N., Rafiei, A., Nikakhlagh, S., Amirrajab, N. and Saki, S., 2013. Prevalence of otomycosis in Khouzestan Province, south-west Iran. The Journal of Laryngology & Otology, 127(1), pp.25-27.

Satish H.S., Viswanatha B. and Manjuladevi M. (2013): A Clinical Study of Otomycosis. IOSR-JDMS; (5.2): 57-62.

Yavo, W., Kassi, R.R., Kiki-Barro, P.C., Bamba, A., Kple, T., Menan, E.I., Ehouo, F. and Koné, M., 2004. Prevalence and risk factors for otomycosis treated in the hospital setting in Abidjan (Ivory Coast). Médecine tropicale: revue du Corps de santé colonial, 64(1), pp.39-42.